Rice Hall James & Associates’s Aspen Aerogels ASPN Stock Holding History
Bought
Maintained
Sold
Other funds holding ASPN
KL
OCMI
NIM
GKFF
Rice Hall James & Associates's ASPN Position: Q2 2026 in Review
Rice Hall James & Associates increased its Aspen Aerogels (ASPN) stake by 5.3% in Q2 2026, buying an estimated $405K and bringing the position to 1,635,259 shares worth $10.4M. The position accounts for 0.5% of the portfolio, ranked #61.
Rice Hall James & Associates first reported a position in ASPN in Q2 2023 and has held it in 13 quarters since. The position peaked at $14.8M in Q3 2024. 180 funds tracked by Wall St. Rank hold ASPN as of Q2 2026.
- Rice Hall James & Associates held 1,635,259 shares of Aspen Aerogels worth $10.4M as of Q2 2026.
- Rice Hall James & Associates bought 82,631 Aspen Aerogels shares in Q2 2026, an estimated $405K.
- Aspen Aerogels made up 0.5% of Rice Hall James & Associates's portfolio in Q2 2026, its #61 holding.
- Rice Hall James & Associates first reported a position in Aspen Aerogels in Q2 2023 and has held it in 13 quarters since.
- Rice Hall James & Associates's Aspen Aerogels position peaked at $14.8M in Q3 2024.
- 180 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2026.
Based on Rice Hall James & Associates's 13F filing for Q2 2026, filed 7 Aug 2026.